Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A combination medication used primarily in endodontic treatment as an intracanal medicament. This formulation combines the traditional calcium hydroxide with silver nanoparticles to enhance antimicrobial efficacy. Silver nanoparticles provide broad-spectrum antibiofilm action with the ability to reach complex anatomies, while calcium hydroxide serves as a gold standard for root canal disinfection. The combination has shown enhanced effectiveness against various oral pathogens, including bacteria and fungi like Candida albicans, compared to calcium hydroxide alone. Silver nanoparticles exert bactericidal properties by breaking cellular membranes, inhibiting metabolic enzymes, and generating reactive oxygen species.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calcium hydroxide + silver nanoparticles.